Ligand validation:8XC3

AKG: 2-OXOGLUTARIC ACID

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8XC3_AKG_B_402	93%	28%	0.062	0.956	1.58	1.33	1	1	0	0	100%	1
8XC3_AKG_A_402	79%	31%	0.083	0.927	1.46	1.27	1	1	0	0	100%	1
8X7C_AKG_B_402	100%	23%	0.041	0.981	1.26	1.92	1	5	0	0	100%	1
8X74_AKG_A_402	97%	30%	0.052	0.965	1.34	1.46	-	1	0	0	100%	1
4GJZ_AKG_A_502	100%	25%	0.024	0.996	1.6	1.43	2	2	0	0	100%	1
4QKB_AKG_A_302	100%	20%	0.031	0.994	1.89	1.52	1	1	0	0	100%	1
3GR9_AKG_H_406	100%	10%	0.04	0.995	1.96	2.36	2	5	0	0	100%	1
8X6Q_AKG_D_403	100%	27%	0.041	0.985	1.35	1.58	1	4	0	0	100%	1
8RE9_AKG_A_801	100%	23%	0.04	0.981	1.21	1.95	2	2	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.